ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Fighting Heartburn and Gerd Naturally – And Safely!

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Natural Bladder Control, Go Less and Live More

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Trimming the spare tire: Canola oil may cut belly fat

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

Curcumin Reverses the Cellular Damage of Chronic Stress

The Onion: Cancer Fighter and Food Preserver

Probiotics improve cognition in Alzheimer's patients

 
Print Page
Email Article

Two Alzheimer's Drugs Show Potential - U.S. Studies

  [ 282 votes ]   [ Discuss This Article ]
www.ProHealth.com • July 23, 2004


By Jon Hurdle

Two experimental Alzheimer's drugs have the potential to prevent or halt the progress of the brain-wasting disease, doctors said on Wednesday. Both focus on beta-amyloid, a protein that is suspected of causing Alzheimer's. It accumulates into the characteristic clogs called plaques that distinguish the brains of people who have died from Alzheimer's.

An estimated 4.5 million Americans have the disease, a number that is expected to grow to 16 million by 2050 as the baby boom generation ages. More than 15 million people globally have Alzheimer's.

In one study at Georgetown University Medical Center in Washington, 58 people with mild to moderate Alzheimer's disease (news - web sites) took a drug called Alzhemed or a placebo for three months, then for an additional 21 months. Alzhemed, made by Montreal, Canada-based Neurochem Inc., is a pill just beginning Phase III trials, the final stage before a company seeks approval from regulators for a new drug.

The study, reported at a meeting of Alzheimer's experts in Philadelphia, found a significant drop in the level of beta-amyloid among patients who took the drug and no change among those taking the placebo. The researchers also found Alzhemed in cerebral spinal fluid, which indicates it was finding its way to the brain where it is needed. The drug reduced the levels of beta-amyloid in the spinal fluid and was generally safe and well tolerated, the researchers found.

TRIAL SET TO EXPAND Among patients who began the trial with mild Alzheimer's, there was no further cognitive decline after 12 months of taking the drug, said Dr. Paul Aisen, who leads the study. There are now 26 patients who have taken the drug for 16 months, and 19 who have taken it for 20 months, Aisen told a news conference. He said the trial will now be expanded. "It will be a large, long trial that will provide a definitive answer on the efficacy of Alzhemed in inhibiting Alzheimer's," Aisen said.

In another study, Eli Lilly & Co. is trying to prevent beta-amyloid from forming in the first place. A trial of 37 healthy adults aged over 45 found blood levels of beta-amyloid were reduced after they took LY450139, an experimental drug designed to interfere with the formation enzymes called secretases, which generate beta-amyloid. The trial found reduced levels of beta-amyloid in the blood after the drug was administered. Higher doses produced a greater reduction. Although the drug was detected in cerebral spinal fluid, it did not reduce concentration of beta-amyloid in the fluid. Researchers need to know the most effective dose before starting a larger trial, said Dr. Eric Siemers of Eli Lilly.

Alzheimer's begins with mild memory loss but can quickly progress to destroy learning, memory and patients' ability to care for themselves. There is no cure and it is always fatal.

Source: Yahoo! news. (C) Reuters. All rights reserved.



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Ultra EPA  - Fish Oil Vitamin D3 Extreme™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Astaxanthin - A Little-Known but Power-Packed Nutrient Astaxanthin - A Little-Known but Power-Packed Nutrient
"It's Not Easy Being Green" - But It Is Healthy
Aching Muscles? Top 10 Nutrients to Take Back Your Life Aching Muscles? Top 10 Nutrients to Take Back Your Life
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map